The US Food and Drug Administration has approved Geparon ER, sold under the brand name Exxua, a first-of-its-kind medication for treating major depressive disorder (MDD), Fabre-Kramer Pharmaceuticals announced last week.…
Copyright © 2023 dailyhealthways.com